Answers are grounded in this paper and cite their sources.
This commentary reviews anti-inflammatory drug effects on acute coronary syndromes, highlighting CANTOS findings and future research implications.
This commentary evaluates anti-inflammatory medications in acute coronary syndrome (ACS), with a focus on the CANTOS trial and emerging treatments. A literature search up to 2024 in PubMed, Embase, and Cochrane was conducted using keywords such as “cardiovascular inflammation” and “CANTOS trial.” It included randomized controlled trials, meta-analyses, and observational studies on the safety and effectiveness of anti-inflammatory drugs in ACS, excluding non-English, nonhuman, and nonpeer-reviewed papers. Key results from CANTOS and other trials were highlighted, along with issues and future research areas.
No takes yet. Share an insight, caveat, or question.
Omar Elsaka (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: